Messenger RNA therapy for treatment of articular disease
US9943595B2 · kind B2 · utility
8Cited by
54References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2015 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Dec 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, among other things, a method of intra-articular delivery of messenger RNA (mRNA), comprising administering into a joint of a subject in need of delivery a composition comprising an mRNA encoding a protein, such that the administering of the composition results in expression of the protein encoded by the mRNA in the joint.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.